LTP GROUP TECHNOLOGY JOINT STOCK COMPANY

LTP Group Technology Joint Stock Company is a subsidiary of the Group, entrusted with the primary mission of investing in and developing biotechnology for medicinal materials.

Adhering to the strategy of applying advanced science and technology to production, LTP Group focuses on investing in, mastering, and effectively utilizing biopharmaceutical material technology. This technology serves as the core foundation of the production line, fulfilling key objectives:

- Extraction and isolation of active compounds: Utilizing vacuum drying and separation technology—operating under controlled pressure and temperature ranges—to extract and concentrate the finest bioactive compounds from precious medicinal materials and key agricultural products.

- Preservation of medicinal properties and quality: Completely eliminating oxidation and thermal degradation, thereby fully preserving the biological structure, medicinal properties, nutritional content, and natural flavor of the raw materials.

- Standardization of output: Thoroughly removing moisture and impurities to produce high-purity finished goods that meet rigorous technical standards for both domestic consumption and export.

By mastering advanced vacuum drying and separation technology, LTP Group Technology Joint Stock Company demonstrates its effective execution capabilities within the strategy to develop the medicinal biotechnology industry, thereby making a practical contribution to the Group's overall sustainable development.